Literature DB >> 21109468

Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.

Leo L K Chen1, Zulfi Haneef, Andrew Dorsch, Inna Keselman, John M Stern.   

Abstract

Lacosamide has been reported to have been successfully used for non-convulsive status epilepticus after benzodiazepine failure, and convulsive status epilepticus after benzodiazepine and levetiracetam failure. We report a case of simple motor status epilepticus refractory to benzodiazepines and multiple anti-epileptic medications (AEDs) over 4 days. The addition of lacosamide in combination with existing levetiracetam aborted the continuous seizure with maintenance of seizure freedom through the most recent follow-up at 4 weeks. Published by Elsevier Ltd.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21109468     DOI： 10.1016/j.seizure.2010.11.004

Source DB:  PubMed          Journal:  Seizure        ISSN： 1059-1311            Impact factor:   3.184


  4 in total

Review 1.  Novel medications for epilepsy.

Authors:  Cinzia Fattore; Emilio Perucca
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

2.  Treatment of nonconvulsive status epilepticus.

Authors:  Trudy Pang; Frank W Drislane
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

3.  Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Stephan Rüegg
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

4.  Treatment of refractory simple partial status epilepticus by the addition of oral lacosamide in neurosurgical patients. Report of 3 cases.

Authors:  Georgios F Hadjigeorgiou; Adamantios Petsanas; Christos Anagnostopoulos; Christos Chamilos; Georgios Vranos; Philokypros Spyridakis
Journal:  Epilepsy Behav Case Rep       Date:  2013-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.